Quantcast

Latest Prenatal diagnosis Stories

2011-02-10 07:00:00

SAN DIEGO, Feb. 10, 2011 /PRNewswire/ -- Sequenom (Nasdaq: SQNM) is very pleased to announce publication in the American Journal of Obstetrics and Gynecology (doi: 10.1016/j.ajog.2010.12.060) of Sequenom CMM's "locked assay" study. (Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO) The paper entitled "Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting" is available through the 'Articles Online First' section of the...

2011-01-14 08:45:28

(Ivanhoe Newswire) -- A test that uses the latest DNA technology to analyze genetic components in a pregnant woman's blood could predict Down's syndrome in unborn babies, according to new research. Down's syndrome occurs when an individual has three, rather than two, copies of the 21st chromosome. This additional genetic material alters the course of development. Older women are at a higher risk of giving birth to a baby with Down's. Women in high-risk groups typically undergo a combination...

2010-10-26 22:18:11

When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis. In HLHS, one of the heart's pumping chambers is severely underdeveloped. However, say researchers, in two-thirds of cases, reconstructive surgery affords the infant an excellent chance of early survival. Researchers from The Children's Hospital of Philadelphia report on five years of experience at...

2010-10-26 07:45:00

PHILADELPHIA, Oct. 26 /PRNewswire-USNewswire/ -- When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis. In HLHS, one of the heart's pumping chambers is severely underdeveloped. However, say researchers, in two-thirds of cases, reconstructive surgery affords the infant an excellent chance of early survival. Researchers from The Children's Hospital...

2010-10-13 13:28:05

Press release from PLoS Medicine Prenatal treatment of congenital toxoplasmosis with antibiotics might substantially reduce the proportion of infected fetuses that develop serious neurological sequelae (brain damage, epilepsy, deafness, blindness, or developmental problems) or die, and could be particularly effective in fetuses whose mothers acquired Toxoplasma gondii, the parasite that causes toxoplasmosis, during the first third of pregnancy. These are the findings of an observational study...

ea49778342fbd1876d919d9c557a38fe1
2010-06-30 11:30:00

Researchers say that a blood test during pregnancy could one day replace more invasive tests for Down's syndrome. Women that are at high-risk are currently offered an amniocentesis test, which carries a risk of miscarriage. However, Dutch researchers told a fertility conference that they are on the verge of developing an accurate way of testing the mother's blood for chromosome disorders in the fetus. Experts said it was promising but too early to determine its effectiveness. The test is...

2010-06-30 03:49:00

LONDON, June 30 /PRNewswire/ -- Frost & Sullivan is pleased to announce that it has awarded its prestigious 2010 Scandinavia New Product Innovation Award to FCMB ApS ("FCMB") for its breakthrough work in non-invasive prenatal testing. FCMB is developing a suite of non-invasive prenatal diagnostics based on isolating fetal cells from maternal blood samples. FCMB's diagnostics have the potential to provide results that are as accurate as more invasive procedures, such as amniocentesis...

2010-04-29 05:00:00

BEIJING, April 29 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it received approval for its AUTOMAGLIA 90 fully-automated ECLIA analyzer ("AUTOMAGLIA 90 Analyzer") as well as Down Syndrome screening kit ("Down Syndrome Screening") from the State Food and Drug Administration of China (the "SFDA"). AUTOMAGLIA 90 Analyzer is a fully-automated...

2010-03-08 13:30:58

New study in the American Journal of Obstetrics & Gynecology explores this controversy Spinal Muscular Atrophy (SMA) is one of many serious disorders for which prenatal testing is available. SMA affects approximately 1 in 10,000 live births and is the leading genetic cause of infant mortality and the second most common autosomal recessive disorder, after cystic fibrosis. Although the American College of Medical Genetics recommends carrier testing for all couples, the American College of...

2010-02-25 08:00:00

PARSIPPANY, N.J. and REDWOOD CITY, Calif., Feb. 25 /PRNewswire/ -- Ferring Pharmaceuticals and Gene Security Network (GSN) announced that they have signed an agreement to conduct a clinical trial of GSN's advanced preimplantation genetic diagnosis (PGD) technology, Parental Support(TM). The 11-center U.S. trial is designed to evaluate if GSN's PGD technology helps increase in vitro fertilization (IVF) success rates when using single cell embryo testing for an abnormal number of...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'